PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $8,980,000 | -35.1% | 1,776,490 | -20.8% | 0.32% | -30.2% |
| Q2 2019 | $13,836,000 | +30.0% | 2,242,503 | -2.2% | 0.46% | +34.1% |
| Q1 2019 | $10,640,000 | +31.7% | 2,293,179 | +19.2% | 0.34% | +16.3% |
| Q4 2018 | $8,079,000 | -4.2% | 1,923,499 | +43.0% | 0.30% | -2.3% |
| Q3 2018 | $8,435,000 | -24.5% | 1,345,260 | -3.2% | 0.30% | -25.6% |
| Q2 2018 | $11,174,000 | +9.0% | 1,389,840 | +1.1% | 0.41% | +1.5% |
| Q1 2018 | $10,253,000 | +24.7% | 1,374,462 | -0.6% | 0.40% | +23.8% |
| Q4 2017 | $8,225,000 | -15.0% | 1,382,407 | +5.1% | 0.32% | -24.5% |
| Q3 2017 | $9,678,000 | +4.4% | 1,314,943 | -3.7% | 0.43% | +6.2% |
| Q2 2017 | $9,268,000 | -10.6% | 1,364,879 | +24.3% | 0.40% | -20.2% |
| Q1 2017 | $10,366,000 | +7.8% | 1,098,116 | -1.3% | 0.50% | +4.1% |
| Q4 2016 | $9,615,000 | +34.5% | 1,112,818 | -1.4% | 0.48% | +29.7% |
| Q3 2016 | $7,147,000 | +75.6% | 1,129,119 | +17.0% | 0.37% | +59.8% |
| Q2 2016 | $4,071,000 | +1.5% | 964,797 | +4.9% | 0.23% | +0.9% |
| Q1 2016 | $4,011,000 | -26.6% | 919,891 | +3.2% | 0.23% | -25.6% |
| Q4 2015 | $5,466,000 | +98.3% | 891,672 | +85.0% | 0.31% | +74.3% |
| Q3 2015 | $2,757,000 | +505.9% | 482,054 | +690.9% | 0.18% | +588.5% |
| Q2 2015 | $455,000 | +43.5% | 60,950 | +15.0% | 0.03% | +44.4% |
| Q1 2015 | $317,000 | +65.1% | 52,997 | +108.9% | 0.02% | +50.0% |
| Q4 2014 | $192,000 | – | 25,364 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|